Compare $AZTR vs $BOLT | Chartloom

Compare

$AZTR vs $BOLT

Azitra Inc · Bolt Biotherapeutics Inc

AZTR

Azitra Inc

BOLT

Bolt Biotherapeutics Inc

Compare $AZTR vs $BOLT

Comparing Azitra Inc and Bolt Biotherapeutics Inc

AZTRAzitra Inc

BOLTBolt Biotherapeutics Inc

AZTRAzitra Inc

Market cap

$2M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-53.4%

52W performance

-82.4%

FCF yield

-531.3%

BOLTBolt Biotherapeutics Inc

Market cap

$8M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

12.8%

YTD performance

-29.0%

52W performance

-35.8%

FCF yield

-399.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

AZTR

BOLT

Detailed metrics comparison

AZTR

Azitra Inc

BOLT

Bolt Biotherapeutics Inc

Market Cap

AZTR$2M

BOLT$8M

Enterprise Value

AZTR$-5M

BOLT$-5M

Price

AZTR$0.13

BOLT$4.11

P/E Ratio

AZTRN/A

BOLTN/A

P/S Ratio

AZTR19.60x

BOLT1.68x

EV/Sales

AZTR3.12x

BOLT-1.06x

EV/EBITDA

AZTR0.00x

BOLT0.00x

P/B Ratio

AZTR1.09x

BOLT0.53x

P/FCF Ratio

AZTRN/A

BOLTN/A

EV/FCF

AZTR0.41x

BOLT0.16x

PEG Ratio

AZTRN/A

BOLTN/A

Forward P/E (NTM)

AZTRN/A

BOLTN/A

Forward P/S (NTM)

AZTRN/A

BOLTN/A

Revenue (TTM)

AZTR$0

BOLT$5M

Revenue Growth (YoY)

AZTRN/A

BOLT12.8%

Forward Rev Growth

AZTR73.2%

BOLT1650.0%

Gross Margin (TTM)

AZTR0.0%

BOLT0.0%

Operating Margin (TTM)

AZTR0.0%

BOLT0.0%

EBITDA Margin (TTM)

AZTR0.0%

BOLT-586.3%

Net Margin (TTM)

AZTR0.0%

BOLT-611.5%

FCF Margin (TTM)

AZTRN/A

BOLT-671.0%

Net Income (TTM)

AZTR$-5M

BOLT$-29M

FCF (TTM)

AZTR$-11M

BOLT$-32M

EPS (TTM)

AZTR$0.00

BOLT-$17.00

ROE (TTM)

AZTR-28475.0%

BOLT-12623.0%

ROA (TTM)

AZTR-17815.0%

BOLT-5470.0%

ROIC (TTM)

AZTR-26746.0%

BOLT-12623.0%

Cash

AZTR$7M

BOLT$13M

Debt

AZTR$2K

BOLT$0

Net Cash/Debt

AZTR$7M

BOLT$13M

Current Ratio (TTM)

AZTR4.86x

BOLT2.61x

Quick Ratio (TTM)

AZTR4.49x

BOLT2.26x

Debt/Equity (TTM)

AZTR0.00x

BOLT0.00x

Debt/Assets (TTM)

AZTR0.0%

BOLT0.0%

Interest Coverage (TTM)

AZTRN/A

BOLTN/A

Net Debt/EBITDA (TTM)

AZTR0.00x

BOLT0.00x

Beta

AZTR-1.00

BOLT0.97

52W Performance

AZTR-82.4%

BOLT-35.8%

YTD Performance

AZTR-53.4%

BOLT-29.0%

% from 52W High

AZTR-88.1%

BOLT-42.9%

% from 52W Low

AZTR29.9%

BOLT32.6%

Asset Turnover (TTM)

AZTR0.07x

BOLT0.09x

FCF Yield (TTM)

AZTR-531.3%

BOLT-399.6%

Earnings Yield (TTM)

AZTR-237.7%

BOLT-364.2%

Dividend Yield (TTM)

AZTRN/A

BOLTN/A

Rule of 40

AZTR0.0

BOLT-658.2

EV/GP/RG

AZTRN/A

BOLTN/A

Ticker research

View AZTR research View BOLT research

Metric	AZTR Azitra Inc	BOLT Bolt Biotherapeutics Inc
Market & Valuation
Market Cap	$2M	$8M
Enterprise Value	$-5M	$-5M
Price	$0.13	$4.11
P/E Ratio	N/A	N/A
P/S Ratio	19.60x	1.68x
EV/Sales	3.12x	-1.06x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.09x	0.53x
P/FCF Ratio	N/A	N/A
EV/FCF	0.41x	0.16x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$5M
Revenue Growth (YoY)	N/A	12.8%
Forward Rev Growth	73.2%	1650.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-586.3%
Net Margin (TTM)	0.0%	-611.5%
FCF Margin (TTM)	N/A	-671.0%
Net Income (TTM)	$-5M	$-29M
FCF (TTM)	$-11M	$-32M
EPS (TTM)	$0.00	-$17.00
ROE (TTM)	-28475.0%	-12623.0%
ROA (TTM)	-17815.0%	-5470.0%
ROIC (TTM)	-26746.0%	-12623.0%
Financial Health
Cash	$7M	$13M
Debt	$2K	$0
Net Cash/Debt	$7M	$13M
Current Ratio (TTM)	4.86x	2.61x
Quick Ratio (TTM)	4.49x	2.26x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-1.00	0.97
52W Performance	-82.4%	-35.8%
YTD Performance	-53.4%	-29.0%
% from 52W High	-88.1%	-42.9%
% from 52W Low	29.9%	32.6%
Efficiency & Yields
Asset Turnover (TTM)	0.07x	0.09x
FCF Yield (TTM)	-531.3%	-399.6%
Earnings Yield (TTM)	-237.7%	-364.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-658.2
EV/GP/RG	N/A	N/A
Ticker research	View AZTR research	View BOLT research

Valuation

P/S Ratio

BOLT

1.68x

AZTR

19.60x

EV/FCF

BOLT

0.16x

AZTR

0.41x

Growth & revenue

Revenue Growth TTM

BOLT

12.8%

Forward Revenue Growth

BOLT

1650.0%

AZTR

73.2%

Profitability & performance

Gross Margin

AZTR

0.0%

BOLT

0.0%

ROE

BOLT

-12623.0%

AZTR

-28475.0%

FCF Yield %

BOLT

-399.6%

AZTR

-531.3%

52-Week Performance

BOLT

-35.8%

AZTR

-82.4%

Detailed metrics comparison

AZTR

Azitra Inc

BOLT

Bolt Biotherapeutics Inc

Market Cap

AZTR$2M

BOLT$8M

Enterprise Value

AZTR$-5M

BOLT$-5M

Price

AZTR$0.13

BOLT$4.11

P/E Ratio

AZTRN/A

BOLTN/A

P/S Ratio

AZTR19.60x

BOLT1.68x

EV/Sales

AZTR3.12x

BOLT-1.06x

EV/EBITDA

AZTR0.00x

BOLT0.00x

P/B Ratio

AZTR1.09x

BOLT0.53x

P/FCF Ratio

AZTRN/A

BOLTN/A

EV/FCF

AZTR0.41x

BOLT0.16x

PEG Ratio

AZTRN/A

BOLTN/A

Forward P/E (NTM)

AZTRN/A

BOLTN/A

Forward P/S (NTM)

AZTRN/A

BOLTN/A

Revenue (TTM)

AZTR$0

BOLT$5M

Revenue Growth (YoY)

AZTRN/A

BOLT12.8%

Forward Rev Growth

AZTR73.2%

BOLT1650.0%

Gross Margin (TTM)

AZTR0.0%

BOLT0.0%

Operating Margin (TTM)

AZTR0.0%

BOLT0.0%

EBITDA Margin (TTM)

AZTR0.0%

BOLT-586.3%

Net Margin (TTM)

AZTR0.0%

BOLT-611.5%

FCF Margin (TTM)

AZTRN/A

BOLT-671.0%

Net Income (TTM)

AZTR$-5M

BOLT$-29M

FCF (TTM)

AZTR$-11M

BOLT$-32M

EPS (TTM)

AZTR$0.00

BOLT-$17.00

ROE (TTM)

AZTR-28475.0%

BOLT-12623.0%

ROA (TTM)

AZTR-17815.0%

BOLT-5470.0%

ROIC (TTM)

AZTR-26746.0%

BOLT-12623.0%

Cash

AZTR$7M

BOLT$13M

Debt

AZTR$2K

BOLT$0

Net Cash/Debt

AZTR$7M

BOLT$13M

Current Ratio (TTM)

AZTR4.86x

BOLT2.61x

Quick Ratio (TTM)

AZTR4.49x

BOLT2.26x

Debt/Equity (TTM)

AZTR0.00x

BOLT0.00x

Debt/Assets (TTM)

AZTR0.0%

BOLT0.0%

Interest Coverage (TTM)

AZTRN/A

BOLTN/A

Net Debt/EBITDA (TTM)

AZTR0.00x

BOLT0.00x

Beta

AZTR-1.00

BOLT0.97

52W Performance

AZTR-82.4%

BOLT-35.8%

YTD Performance

AZTR-53.4%

BOLT-29.0%

% from 52W High

AZTR-88.1%

BOLT-42.9%

% from 52W Low

AZTR29.9%

BOLT32.6%

Asset Turnover (TTM)

AZTR0.07x

BOLT0.09x

FCF Yield (TTM)

AZTR-531.3%

BOLT-399.6%

Earnings Yield (TTM)

AZTR-237.7%

BOLT-364.2%

Dividend Yield (TTM)

AZTRN/A

BOLTN/A

Rule of 40

AZTR0.0

BOLT-658.2

EV/GP/RG

AZTRN/A

BOLTN/A

Ticker research

View AZTR research View BOLT research

Metric	AZTR Azitra Inc	BOLT Bolt Biotherapeutics Inc
Market & Valuation
Market Cap	$2M	$8M
Enterprise Value	$-5M	$-5M
Price	$0.13	$4.11
P/E Ratio	N/A	N/A
P/S Ratio	19.60x	1.68x
EV/Sales	3.12x	-1.06x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.09x	0.53x
P/FCF Ratio	N/A	N/A
EV/FCF	0.41x	0.16x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$5M
Revenue Growth (YoY)	N/A	12.8%
Forward Rev Growth	73.2%	1650.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-586.3%
Net Margin (TTM)	0.0%	-611.5%
FCF Margin (TTM)	N/A	-671.0%
Net Income (TTM)	$-5M	$-29M
FCF (TTM)	$-11M	$-32M
EPS (TTM)	$0.00	-$17.00
ROE (TTM)	-28475.0%	-12623.0%
ROA (TTM)	-17815.0%	-5470.0%
ROIC (TTM)	-26746.0%	-12623.0%
Financial Health
Cash	$7M	$13M
Debt	$2K	$0
Net Cash/Debt	$7M	$13M
Current Ratio (TTM)	4.86x	2.61x
Quick Ratio (TTM)	4.49x	2.26x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-1.00	0.97
52W Performance	-82.4%	-35.8%
YTD Performance	-53.4%	-29.0%
% from 52W High	-88.1%	-42.9%
% from 52W Low	29.9%	32.6%
Efficiency & Yields
Asset Turnover (TTM)	0.07x	0.09x
FCF Yield (TTM)	-531.3%	-399.6%
Earnings Yield (TTM)	-237.7%	-364.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-658.2
EV/GP/RG	N/A	N/A
Ticker research	View AZTR research	View BOLT research